ml-3000 has been researched along with Gastric Ulcer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Kerdawy, AM; Gedawy, EM; Kassab, AE | 1 |
| Kulkarni, SK; Patil, CS; Singh, VP | 1 |
| Carter, L; Laufer, S; McKnight, W; Tries, S; Wallace, JL | 1 |
4 other study(ies) available for ml-3000 and Gastric Ulcer
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Arachidonate 5-Lipoxygenase; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Drug Design; Humans; Lipoxygenase Inhibitors; Male; Mice; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Sulfonamides | 2020 |
Effect of licofelone against NSAIDs-induced gastrointestinal ulceration and inflammation.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Humans; Indomethacin; Inflammation; Leukotriene B4; Lipid Peroxidation; Male; Mesentery; Mice; Neutrophils; Pyrroles; Rats; Stomach Ulcer; Time Factors | 2005 |
ML 3000 reduces gastric prostaglandin synthesis without causing mucosal injury.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cyclooxygenase Inhibitors; Gastric Mucosa; Leukocytes; Lipoxygenase Inhibitors; Male; Prostaglandins; Pyrroles; Rabbits; Rats; Rats, Wistar; Stomach Ulcer | 1994 |
[Double blockade should protect the stomach. New approach to rheumatism].
Topics: Acetates; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Lipoxygenase Inhibitors; Osteoarthritis; Pyrroles; Stomach Ulcer | 2001 |